A statistical method for identifying differential gene-gene co-expression patterns

Bioinformatics

Volumn 20, Issue 17, 2004, Pages 3146-3155

  Lai, Yinglei ^a   Wu, Baolin ^a   Chen, Liang ^b   Zhao, Hongyu ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; ADIPSIN; GLUTATHIONE TRANSFERASE; MITOCHONDRIAL PROTEIN; NUCLEOSIDE DIPHOSPHATE KINASE A; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; RACEMASE; RGS PROTEIN; SERINE PROTEINASE; T LYMPHOCYTE RECEPTOR;

ARTICLE; CARCINOGENESIS; CORRELATION ANALYSIS; DNA MICROARRAY; GENE EXPRESSION; GENE IDENTIFICATION; GENE LOCATION; GENETIC ASSOCIATION; INFORMATION PROCESSING; NUCLEOTIDE SEQUENCE; PATTERN RECOGNITION; PRIORITY JOURNAL; PROSTATE CANCER; STATISTICAL ANALYSIS; STATISTICAL CONCEPTS; TUMOR SUPPRESSOR GENE;

EID: 10244219943     PISSN: 13674803     EISSN: 13674811     Source Type: Journal    
DOI: 10.1093/bioinformatics/bth379     Document Type: Article

References (28)

1. Benjamini,Y. and Hochberg,Y. (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J. R. Stat. Soc. Ser. B, 57, 289-300.
2. Campbell,K.J., Rocha,S. and Perkins,N.D. (2004) Active repression of antiapoptotic gene expression by RelA (p65) NF-kappa B. Mol. Cell, 13, 853-865.
3. Chau,B.N. and Wang,J.Y.J. (2003) Coordinated regulation of life and death by RB. Nat. Rev. Cancer, 3, 130-138.
4. Chen,G.A., Gharib,T.G., Huang,C.C., Taylor,J.M.G., Misek,D.E., Kardia,S.L.R., Giordano,T.J., Iannettoni,M.D., Orringer,M.B., Hanash,S.M. and Beer,D.G. (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics, 1, 304-313.
5. Cherepinsky,V., Feng,J.W., Rejali,M. and Mishra,B. (2003) Shrinkage-based similarity metric for cluster analysis of microarray data. Proc. Natl Acad. Sci. USA, 100, 9668-9673.
6. Eisen,M.B., Spellman,P.T., Brown,P.O. and Botstein,D. (1998) Cluster analysis and display of genome-wide expression patterns. Proc. Natl Acad. Sci., USA, 95, 14863-14868.
7. DeMarzo,A.M., Meeker,A.K., Zha,S., Luo,J., Nakayama,M., Platz,E.A., Isaacs,W.B. and Nelson,W.G. (2003a) Human prostate cancer precursors and pathobiology. Urology, 62 (Suppl. 5A), 55-62.
8. DeMarzo,A.M., Nelson,W.G., Isaacs,W.B. and Epstein,J.I. (2003b) Pathological and molecular aspects of prostate cancer. Lancet 361, 955-964.
9. DeRisi,J.L., Iyer,V.R. and Brown,P.O. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science, 278, 680-686.
10. Golub,T.R., Slonim,D.K., Tamayo,P., Huard,C., Gaasenbeek,M., Mesirov,J.P., Coller,H., Loh,M.L., Downing,J.R., Caligiuri,M.A., Bloomfield,C.D. and Lander,E.S. (1999) Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science, 286, 531-537.
11. Gygi,S.P., Rochon,Y., Franza,B.R. and Aebersold,R. (1999) Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol., 19, 1720-1730.
12. Hahn,W.C. and Weinberg,R.A. (2002) Modelling the molecular circuitry of cancer. Nat. Rev. Cancer, 2, 331-341.
13. Lashkari,D.A., DeRisi,J.L., McCusker,J.H., Namath,A.F., Gentile,C., Hwang,S.Y., Brown,P.O. and Davis,R.W. (1997) Yeast microarrays for genome wide parallel genetic and gene expression analysis. Proc. Natl Acad. Sci., USA, 94, 13057-13062.
14. Li,K.C. (2002) Genome-wide co-expression dynamics: theory and application. Proc. Natl Acad. Sci., USA, 99, 16875-16880.
15. Marcotte,E.M., Pellegrini,M., Thompson,M.J., Yeates,T.O. and Eisenberg,D. (1999) A combined algorithm for genome-wide prediction of protein function. Nature, 402, 83-86.
16. Royston,J.P. (1982) An extension of Shapiro and Wilk's W test for normality to large samples. Appl. Stat., 31, 115-124.
17. Rubin,M.A., Zhou,M., Dhanasekaran,S.M., Varambally,S., Barrette,T.R., Sanda,M.G., Pienta,K.J., Ghosh,D. and Chinnaiyan,A.M. (2002) α-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA, 287, 1662-1670.
18. Schena,M., Shalon,D., Davis,R.W. and Brown,P.O. (1995) Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science, 270, 467-470.
19. Shapiro,S.S. and Wilk,M.B. (1965) An analysis of variance test for normality (complete samples). Biometrika, 52, 591-611.
20. Singh,D., Febbo,P.G., Ross,K., Jackson,D.G., Manola,J., Ladd,C., Tamayo,P., Renshaw,A.A., D'Amico,A.V., Richie,J.P. et al. (2002) Gene expression correlates of clinical prostate cancer behavior. Cancer Cell, 1, 203-209.
21. Spellman,P.T., Sherlock,G., Zhang,M.Q., Iyer,V.R., Anders,K., Eisen,M.B., Brown,P.O., Botstein,D. and Futcher,B. (1998) Comprehensive identification of cell cycle-regulated genes of the yeast Saccharomyces cerevisiae by microarray hybridization. Mol. Biol. Cell, 9, 3273-3297.
22. Stephan,C., Yousef,G.M., Scorilas,A., Jung,K., Jung,M., Kristiansen,G., Hauptmann,S., Kishi,T., Nakamura,T., Loening,S.A. and Diamandis,E.P. (2004) Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer. J. Urol., 171, 187-191.
23. Tusher,V.G., Tibshirani,R. and Chu,G. (2001) Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl Acad. Sci. USA, 98, 5116-5121.
24. van't Veer,L.J., Dai,H.Y., van de VijverM.J., He,Y.D.D., Hart,A.A.M., Mao,M., Peterse,H.L., van der Kooy,K., Marton,M.J., Witteveen,A.T. et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature, 415, 530-536.
25. Visakorpi,T. (2003) The molecular genetics of prostate cancer. Urology, 62 (Suppl. 5A), 3-10.
26. Vousden,K.H. and Lu,X. (2002) Live or let die: the cell's response to p53. Nat. Rev. Cancer, 2, 594-604.
27. Washburn,M.P., Koller,A., Oshiro,G., Ulaszek,R.R., Plouffe,D., Deciu,C., Winzeler,E. and Yates,J.R.,III, (2003) Protein pathway and complex clustering of correlated mRNA and protein expression analyses in Saccharomyces cerevisiae. Proc. Natl Acad. Sci., USA, 100, 3107-3112.
28. Willis,A., Jung,E.J., Wakefield,T. and Chen,X.B. (2004) Mutant p53 exerts a dominant negative effect by preventing wild-type p53 from binding to the promoter of its target genes. Oncogene, 23 2330-2338.